menu
    • menu

    Company profile for Praxis Pharmaceutical

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Praxis Pharmaceutical is a company that works in the Health Sciences, based in the Parque Tecnológico de Miñano, Álava, and which operates in Europe and Latin America. Our corporate purpose is development and manufacturing for third parties, as well as the marketing of pharmaceutical products specialised in the treatment of orphan and low-incidence indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Praxis PharmaceuticalSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Business Park, Av. de Castilla, 2, Edificio D 2ª Planta, 28830 San Fernando d...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.grupo-praxis.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HiberCell leverages soft skill tools in buyout
    HiberCell leverages soft skill tools in buyout

    16 Aug 2021

    // ENDPTS

    https://endpts.com/cancer-specialist-hibercell-snaps-up-analytics-computational-tools-in-all-stock-buyout-praxis-reveals-new-perimenopausal-depression-data/

    ENDPTS
    16 Aug 2021
    Share Share
    Praxis Bioresearch Awarded $2.9 M Fast-Track SBIR Grant
    Praxis Bioresearch Awarded $2.9 M Fast-Track SBIR Grant

    05 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/05/2275236/0/en/Praxis-Bioresearch-Awarded-2-9-Million-Fast-Track-SBIR-Grant-for-Development-of-Novel-Therapy-for-Apathy-in-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    05 Aug 2021
    Share Share
    Praxis Bioresearch Announces Positive Results for PRX-P4-003
    Praxis Bioresearch Announces Positive Results for PRX-P4-003

    23 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/23/2251571/0/en/Praxis-Bioresearch-Announces-Positive-Results-from-Clinical-Microdose-Study-in-Humans-Showing-Oral-Activation-of-Its-Novel-Prodrug-Stimulant-PRX-P4-003.html

    GLOBENEWSWIRE
    23 Jun 2021
    Share Share
    Praxis Precision Medicines Receives Rare Pediatric Disease
    Praxis Precision Medicines Receives Rare Pediatric Disease

    07 Jan 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/01/07/2154881/0/en/Praxis-Precision-Medicines-Receives-Rare-Pediatric-Disease-and-Orphan-Drug-Designations-for-Severe-Pediatric-Epilepsy-Programs.html

    GLOBENEWSWIRE
    07 Jan 2021
    Share Share
    Praxis, on a roll, bumps up IPO target to $175M
    Praxis, on a roll, bumps up IPO target to $175M

    15 Oct 2020

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/while-iron-hot-praxis-bumps-up-ipo-target-to-175m

    Amirah Al Idrus FIERCE BIOTECH
    15 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search